Advertisement
Screener

Five Prime Therapeutics, Inc. Form D

Five Prime Therapeutics, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2014-03-26: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2014-03-19; Total offering amount $21,040,488.
  • 2012-04-20: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2012-04-16; Total offering amount $10,000,000.
  • 2010-09-16: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2010-08-03; Total offering amount $7,499,999.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2014-03-26Rule 506(b)Equity2014-03-19$21,040,488$21,040,488$01
2012-04-20Rule 506Equity2012-04-16$10,000,000$10,000,000$01
2010-09-16Rule 506Equity2010-08-03$7,499,999$7,499,999$01